Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management

• Main Authors: Sukhbir Singh (Author), Neha Tiwary (Author), Neelam Sharma (Author), Tapan Behl (Author), Anita Antil (Author), Md. Khalid Anwer (Author), Seema Ramniwas (Author), Monika Sachdeva (Author), Gehan M. Elossaily (Author), Monica Gulati (Author), Shreesh Ohja (Author)
• Format: Book
• Published: MDPI AG, 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Disease-modifying anti-rheumatic drugs (DMARDs) is a class of anti-rheumatic medicines that are frequently prescribed to patients suffering from rheumatoid arthritis (RA). Methotrexate, sulfasalazine, hydroxychloroquine, and azathioprine are examples of non-biologic DMARDs that are being used for al...